PharmaEngine, Inc. Stock Price

TPEX:4162 Community·NT$7.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

4162 Share Price Performance

NT$54.40

-33.50 (-38.11%)

NT$54.40

-33.50 (-38.11%)

NT$54.40

Sat, 25 Apr 26

Share Pricen/a

4162 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

2 Risks

1 Reward

View Full Analysis

PharmaEngine, Inc. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 2.70
: 94.31%
: 42.53%
: 0%

View Full Analysis

About 4162

Founded: 2002
Employees: 45
CEO: Hong-Ren Wang
WebsiteView website: www.pharmaengine.com

PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. The company is also developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.